Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Duloxetine Compared to NSIADs in Osteoarthritis of Knee
NCT05486026Phase 2Completed
- Sponsor
- Hawler Medical University
- Start
- Aug 2022
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of duloxetine in osteoarthritis (OA) (2 arms), sponsored by Hawler Medical University. Primary endpoints: Twenty four hour average pain score at 2 months and Western Ontario and McMaster Universities Osteoarthritis Index at 2 months. Started Aug 2022; status: completed.
02
Drugs
duloxetine
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT05486026.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05486026.